Guest guest Posted September 12, 2009 Report Share Posted September 12, 2009 Just read the notes from the international CCVI meeting. Wo9w, Based on what I've learned I am doing ntwo things Giving up liver and pursuing CCVI treatment. I picked several points out of the notes that I thought were interresting. EAE is unsatisfactory as a model of CCSVI one study showed that iron deficient mice could not develop EAE, and that may be applicable. MS lesions are found in white and gray matter. 60% of all lesions are not visible on MRI, they are in the cortex. Preliminary results are exciting to see a reduction of brain atrophy and iron accumulation after the procedure-MS patients have 40% less veins in the brain than the controls. Agaqin, WOW....Lydia Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 26, 2009 Report Share Posted November 26, 2009 oh and by the way guys, It's CCSVI (Chronic CerebroSpinal Venous Insufficiency) not CCVI 'What we do in life, echoes through eternity.' MARCUS AURELIUS (121 - 180 A.D.) To: mscured From: trekkie323@... Date: Thu, 26 Nov 2009 03:20:34 +0000 Subject: Re: CCVI Hi Lydia, _________________________________________________________________ Looking to move this spring? With all the lastest places, searching has never been easier. Look now! http://clk.atdmt.com/NMN/go/157631292/direct/01/ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 22, 2010 Report Share Posted February 22, 2010 UK has been bit slow on this. I believe it has atleast started testing (not correction yet) Other countries have already started treating (Poland, Serbia, India) Please see more details at thisisms.com > > > http://www.bentham.org/cnr/openaccessarticles/cnr6-3/Paolo%20ZamboniII.pdf > > What are others doing to help this situation? > > All I can find that might help is horse chestnut, pycnogenol, prickly ash, grapeseed extract, hawthorn extract, gingko biloba, cayenne. > > Janet > > > _________________________________________________________________ > More than messages–check out the rest of the Windows Live™. > http://www.microsoft.com/windows/windowslive/ > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 7, 2010 Report Share Posted March 7, 2010 CCSVI Breaking News By Dr. Corboy, Co-Director of the Rocky Mountain MS Center at Anschutz Medical Campus Chronic cerebrospinal venous insufficiency (CCSVI) is now a term familiar to most of us. On February 10, 2010, the University of Buffalo released study results from the first U.S. study looking into the possible link between MS and restricted blood flow from the brain. The theory was initially introduced by an Italian researcher, Dr. o Zamboni, who theorized that the narrowing of the extracranial veins is related to—or possibly causes—MS. CCSVI, as defined by Dr. Zamboni, is the narrowing of veins—and consequent obstruction of blood flow—between the brain and spinal cord, and the heart. The thought is that the abnormal flow of blood through the central nervous system (CNS) damages brain and spinal tissue, thus explaining the nerve damage characteristic of MS. Dr. Zamboni’s original study included 65 MS patients and 235 controls. The physician’s study findings suggested that the venous condition was strongly linked to MS, and may increase the risk of MS by 43 fold. The recently released results are from the first phase of the University of Buffalo study, which began in April 2009 and included 500 study participants. The second phase of the study will include an additional 500 patients. This second group of patients will be assessed with more advanced diagnostic tools than those used in the first phase. Therefore, the recently released study results are preliminary. CCSVI (continued) Breaking News Study participants included individuals with a diagnosis of MS (most with RRMS), clinically isolated syndrome (CIS), “other neurologic diseases†(OND), and healthy controls. Participants were tested for CCSVI through the use of ultrasound (Doppler) scans of the head and neck. This made it possible for study investigators to evaluate the direction of venous blood flow. Study participants with MS also received MRI scans, which measured iron deposits in brain lesions and surrounding areas. Overall, researchers found that more than 55% of the 500 study participants exhibited restricted blood flow. More specifically, up to 62.4% of MS patients in the study (excluding the 10.2% of patients who were border line) exhibited signs of CCSVI compared to 25.9% of healthy controls. Study results also suggested a correlation between disease progression and CCSVI, although little information on that is available at this time. It remains unclear whether CCSVI is a risk factor for MS or a result of MS—that’s to say the narrowing of veins is a consequence of the MS disease process. Further studies are necessary before researchers will begin to uncover the answer to that question. The NMSS has set aside a significant amount of money to study this further, with a grant review in May, 2010. Many outstanding issues and questions remain. They include: whether the apparent venous changes are a cause or a result of MS; whether the small drops in pressure detected by Dr. Zamboni after stenting are truly capable of inducing changes pathologically; whether it is possible to induce MS-like pathology by constricting veins in an animal model of MS; how venous backflow might induce MS pathology; why immunotherapies would work if the underlying problem is venous constriction; whether stenting produces favorable outcomes in controlled studies; and many others. </HTML> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.